Today is World Kidney Day. Hundreds of events across the globe are taking place “to raise awareness of the importance of our kidneys to our overall health and to reduce the frequency and impact of kidney disease and its associated health problems worldwide.” (Side note: in recognition that today is also International Women’s Day, World … Continue reading It’s World Kidney Day: Highlighting CIRM’s Investments in Treating Kidney Failure
Disease Areas
A shot in the arm for people with bad knees
Almost every day I get an email or phone call from someone asking if we have a stem cell therapy for bad knees. The inquiries are from people who’ve been told they need surgery to replace joints damaged by age and arthritis. They’re not alone. Every year around 600,000 Americans get a knee replacement. That … Continue reading A shot in the arm for people with bad knees
Breaking the isolation of rare diseases
How can something that affects 30 million Americans, one in ten people in the US, be called rare? But that’s the case with people who have a rare disease. There are around 7,000 different diseases that are categorized as rare because they affect fewer than 200,000 people. Less than five percent of these diseases have … Continue reading Breaking the isolation of rare diseases
Friday Roundup: A better kind of blood stem cell transplant; Encouraging news from spinal cord injury trial; Finding an “elusive” cell that could help diabetics
Cool Instagram image of the week: Chemo- and radiation-free blood stem cell transplant showing promise Bubble baby disease, also known as severe combined immunodeficiency (SCID), is an inherited disorder that leaves newborns without an effective immune system. Currently, the only approved treatment for SCID is a blood stem cell transplant, in which the patient’s defective … Continue reading Friday Roundup: A better kind of blood stem cell transplant; Encouraging news from spinal cord injury trial; Finding an “elusive” cell that could help diabetics
Gladstone scientists tackle heart failure by repairing the heart from within
Modern medicine often involves the development of a drug or treatment outside the body, which is then given to a patient to fix, improve or even prevent their condition. But what if you could regenerate or heal the body using the cells and tissue already inside a patient? Scientists at the Gladstone Institutes are pursuing … Continue reading Gladstone scientists tackle heart failure by repairing the heart from within
Researchers find connection between aging muscles and mutations in stem cells
It’s a humbling fact of life that our muscles decline as we age which is why you didn’t see any 50-year-olds competing for Olympic Gold in figure skating at the 2018 Winter Games. You can blame your muscle stem cells for this. Also called satellite cells, these adult stem cells lie mostly dormant in muscle … Continue reading Researchers find connection between aging muscles and mutations in stem cells
Scientists repair spinal cord injuries in monkeys using human stem cells
An exciting development for spinal cord injury research was published this week in the journal Nature Medicine. Scientists from the University of San Diego School of Medicine transplanted human neural progenitor cells (NPCs) into rhesus monkeys that had spinal cord injuries. These cells, which are capable of turning into other cells in the brain, survived … Continue reading Scientists repair spinal cord injuries in monkeys using human stem cells
Stem Cell Roundup: Improving muscle function in muscular dystrophy; Building a better brain; Boosting efficiency in making iPSC’s
Here are the stem cell stories that caught our eye this week. Photos of the week TGIF! We’re so excited that the weekend is here that we are sharing not one but TWO amazing stem cell photos of the week. Photo #1 is borrowed from a blog we wrote earlier this week about a new … Continue reading Stem Cell Roundup: Improving muscle function in muscular dystrophy; Building a better brain; Boosting efficiency in making iPSC’s
Stem Cell Agency invests in stem cell therapies targeting sickle cell disease and solid cancers
Today CIRM’s governing Board invested almost $10 million in stem cell research for sickle cell disease and patients with solid cancer tumors. Clinical trial for sickle cell disease City of Hope was awarded $5.74 million to launch a Phase 1 clinical trial testing a stem cell-based therapy for adult patients with severe sickle cell disease … Continue reading Stem Cell Agency invests in stem cell therapies targeting sickle cell disease and solid cancers
Stem cell-based gut-on-a-chip: a new path to personalized medicine
“Personalized medicine” is a trendy phrase these days, frequently used in TV ads for hospitals, newspaper articles about medicine’s future and even here in the Stem Cellar. The basic gist is that by analyzing a patient’s unique biology, a physician can use disease treatments that are most likely to work in that individual. This concept … Continue reading Stem cell-based gut-on-a-chip: a new path to personalized medicine
The Stem Cellar 